Sucroferric Oxyhydroxide
Brand name: Velphoro
Rank #107 of 500 drugs by total cost
$166.8M
Total Cost
54,837
Total Claims
$166.8M
Total Cost
1,703
Prescribers
$3,041
Cost per Claim
6,838
Beneficiaries
64,345
30-Day Fills
$98K
Avg Cost/Provider
32
Avg Claims/Provider
About Sucroferric Oxyhydroxide
Sucroferric Oxyhydroxide (sold as Velphoro) was prescribed 54,837 times by 1,703 Medicare Part D providers in 2023, costing the program $166.8M. At $3,041 per claim, this is a high-cost medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 104 | Tamsulosin Hcl (Tamsulosin Hcl) | $168.5M | 8,367,036 |
| 105 | Carbidopa/Levodopa (Carbidopa-Levodopa) | $168.3M | 1,361,770 |
| 106 | Duloxetine Hcl (Duloxetine Hcl) | $167.7M | 5,106,690 |
| 107 | Sucroferric Oxyhydroxide (Velphoro) | $166.8M | 54,837 |
| 108 | Lifitegrast (Xiidra) | $166.6M | 149,269 |
| 109 | Alirocumab (Praluent Pen) | $165.6M | 203,805 |
| 110 | Pantoprazole Sodium (Pantoprazole Sodium) | $165.1M | 10,061,854 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology